Skip to main content
Premium Trial:

Request an Annual Quote

FDA Grants Emergency Use Authorizations for Quest Coronavirus Assays

NEW YORK — The US Food and Drug Administration on Wednesday issued Emergency Use Authorizations for three SARS-CoV-2 tests from Quest Diagnostics that use nasal swab self-collection devices.

Quest's PF SARS-CoV-2 Assay is performed using Hologic's Panther Fusion SARS-CoV-2 RT-PCR-based test, its RC SARS-CoV-2 Assay is performed using Roche's automated Cobas SARS-CoV-2 RT-PCR test, and its HA SARS-CoV-2 Assay is performed using Hologic's Aptima SARS-CoV-2 test.

All three tests are RT-PCR-based and have previously received EUA from the FDA.

According to the FDA, the three Quest assays use nasal swab samples collected using the company's Self-Collection Kit for COVID-19 or other authorized home-collection kit while observed by a healthcare provider via telemedicine.

Collected samples are shipped to Quest-designated laboratories CLIA-certified to perform high-complexity tests, the FDA said.

The Scan

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.

Family Genetic Risk Score Linked to Diagnostic Trajectory in Psychiatric Disorders

Researchers in JAMA Psychiatry find ties between high or low family genetic risk scores and diagnostic stability or change in four major psychiatric disorders over time.

Study Questions Existence of Fetal Microbiome

A study appearing in Nature this week suggests that the reported fetal microbiome might be the result of sample contamination.

Fruit Fly Study Explores Gut Microbiome Effects on Circadian Rhythm

With gut microbiome and gene expression experiments, researchers in PNAS see signs that the microbiome contributes to circadian rhythm synchronicity and stability in fruit flies.